SFM
AMAG

Systematic Financial Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Systematic Financial Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-40,230
Closed -$308K – 501
2020
Q2 		$308K Buy
+40,230
New +$308K 0.02% 347
2019
Q4 		– Sell
-44,970
Closed -$519K – 592
2019
Q3 		$519K Sell
44,970
-47,025
-51% -$495K 0.02% 382
2019
Q2 		$919K Buy
91,995
+5,755
+7% +$62.1K 0.04% 363
2019
Q1 		$1.11M Buy
86,240
+12,635
+17% +$188K 0.04% 457
2018
Q4 		$1.12M Buy
73,605
+14,085
+24% +$268K 0.03% 408
2018
Q3 		$1.19M Sell
59,520
-2,700
-4% -$61.5K 0.03% 520
2018
Q2 		$1.21M Sell
62,220
-12,715
-17% -$281K 0.03% 514
2018
Q1 		$1.51M Sell
74,935
-36,600
-33% -$619K 0.03% 298
2017
Q4 		$1.48M Buy
111,535
+26,945
+32% +$406K 0.03% 408
2017
Q3 		$1.56M Sell
84,590
-7,715
-8% -$144K 0.03% 392
2017
Q2 		$1.7M Buy
92,305
+16,970
+23% +$336K 0.03% 444
2017
Q1 		$1.7M Sell
75,335
-81,105
-52% -$1.94M 0.03% 439
2016
Q4 		$5.44M Buy
156,440
+86,645
+124% +$2.59M 0.09% 260
2016
Q3 		$1.71M Sell
69,795
-4,190
-6% -$105K 0.02% 441
2016
Q2 		$1.77M Buy
73,985
+11,895
+19% +$273K 0.02% 421
2016
Q1 		$1.45M Buy
62,090
+185
+0.3% +$4.39K 0.02% 479
2015
Q4 		$1.87M Sell
61,905
-57,920
-48% -$1.87M 0.02% 342
2015
Q3 		$4.76M Buy
+119,825
New +$7.44M 0.05% 292

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Systematic Financial Management's AMAG Position: Q3 2020 in Review

Systematic Financial Management sold out of AMAG Pharmaceuticals (AMAG) in Q3 2020, closing a stake of 40,230 shares — an estimated $308K sold.

Systematic Financial Management first reported a position in AMAG in Q3 2015 and held it in 18 quarters. The position peaked at $5.44M in Q4 2016. 113 funds tracked by Wall St. Rank hold AMAG as of Q3 2020.

  • Systematic Financial Management reported no remaining AMAG Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Systematic Financial Management sold 40,230 AMAG Pharmaceuticals shares in Q3 2020, an estimated $308K.
  • Systematic Financial Management first reported a position in AMAG Pharmaceuticals in Q3 2015 and held it in 18 quarters.
  • Systematic Financial Management's AMAG Pharmaceuticals position peaked at $5.44M in Q4 2016.
  • 113 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2020.

Based on Systematic Financial Management's 13F filing for Q3 2020, filed 12 Nov 2020.